@lchfRD @DrNadolsky I've linked 3 papers in this QT. Regarding cost, paying out of pocket would be tough for sure. But there are patients with insurance that will cover such medications. And the time will come when such medications go off patent. https:/

@Fitbiter @DrNadolsky @lchfRD There's actually quite a bit of data that not only indicates it doesn't, but that long acting GLP-1 agonists have the opposite effect both in pre-clinical and clinical studies. https://t.co/57QyNNqgaY https://t.co/3ZjYhHbZAR